Metonitazene: Research, Effects, Risks & Safety

Metonitazene is a potent synthetic opioid belonging to the nitazene class of benzimidazole opioids. This compound was first investigated as a potential opioid analgesic. However, it was not developed as an approved medicine due to major safety concerns and opioid-related adverse effects. Today, metonitazene is primarily a topic of discussion in forensic, toxicological and scientific research. WHO reports that it has no known therapeutic application.

What Is Metonitazene?

Metonitazene is a synthetic compound that acts as a mu-opioid receptor agonist. It is part of the larger group of nitazene opioids , a group of several very powerful synthetic opioids .

Metonitazene has a molecular formula of C21H26N4O3 and a molecular weight of approximately 382.5 g/mol, according to PubChem. Its CAS Registry Number is 14680-51-4.

The compound was first prepared in the late 1950’s during research on new opiod analgesics. Early studies demonstrated potent analgesic activity, but metonitazene was not pursued as an approved therapeutic drug because of its safety profile.

What is metonitazene?

Mu-opioid receptor function

Metonitazene has high affinity for the mu-opioid receptor, the same receptor system upon which many conventional opioids act.

This produces the analgesic and sedative effects of opioid receptor activation. But it can also interfere with breathing. The strong opioid effects of fentanyl constitute a particularly serious safety concern.

In laboratory and pre-clinical studies, WHO’s review found significant opioid activity. Reported analgesic potency varied considerably with the experimental model and route of administration.

Metonitazene Effects And Dangers

Since metonitazene is a potent opioid, exposure may lead to effects consistent with opioid receptor activation.

Effects of Opioids Reported

Has been linked to research and clinical information on:

• Analgetic effects
• Sedatives
• Respiration depression
• Vomiting and nausea
• Central nervous system effects, opioid type
• Possible physical dependence
• Potential for abuse and dependence

Most importantly, respiratory depression can be fatal. WHO has reported deaths associated with, including cases where metonitazene was identified with other substances and some cases where it was the only substance detected.

Why is metonitazene dangerous?

“Opioids are very potent and the unpredictability of exposure is the greatest concern. Unregulated synthetic opioids may be present in counterfeit or contaminated drug products that the user does not know about.

WHO has reported cases where metonitazene has been detected in counterfeit opioid products. Unexpected exposure can pose a serious overdose risk as people may believe they are taking another medication.

In addition, taking potent opioids with other central nervous system depressants can cause profound sedation, respiratory depression, coma, and death.

Is Metonitazene legal for medical use?

None. Metonitazene is not an approved therapeutic agent. WHO expert review concluded it has no known therapeutic usefulness and its pharmacological profile carries substantial potential for harm.

Its legal status may vary by jurisdiction as well. For example, PubChem lists it as a DEA Schedule I controlled substance in the United States. Always check local laws in your country before handling any controlled research chemical.

 in research studies

Researchers may study metonitazene to gain a better understanding of synthetic opioids, the pharmacology of opioid receptors, forensic toxicology and emerging drug threats.

Scientific study may assist laboratories in detecting metonitazene in biological samples, and may assist public-health authorities in understanding exposure and overdose patterns.

That said, research status does not mean a compound is safe to ingest in humans. Normal medicine, supplements, and all-purpose chemicals do not contain metonitazene.

Metonitazene Safety Information

Metonitazene is a potent opioid and a serious safety threat. “Severe toxicity can result from accidental exposure or the unexpected presence in another product.”

If someone may have been exposed and develops extreme sleepiness, difficulty staying awake, slow or abnormal breathing, unconsciousness or other signs of opioid poisoning, seek emergency medical help immediately.

Conclusion:

Metonitazene is a core compound in the research of new synthetic opioids but is not an approved medicine. It is a high risk substance because of its strong mu-opioid receptor activity, potential for respiratory depression, risk of dependence and association with fatal cases. Information on metonitazene, therefore, should be directed to scientific research, toxicology, public-health education, and laboratory identification rather than to human use.